Bassam Francis Matti

Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms

Samir Mouhssine, Nawar Maher, Bassam Francis Matti et al. · International Journal of Molecular Sciences · 2024 · 26 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Receptor Tyrosine Kinase +14

Prospective single-center study of chronic myeloid leukemia in chronic phase: switching from branded imatinib to a copy drug and back

A Alwan, Bassam Francis Matti, Abdulsalam H. Muhammed · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 25 citations

Chronic Phase, Hematological Malignancy, Chronic Myeloid Leukemia +13

Evaluation of the Safety of Imatinib Mesylate in 200 Iraqi Patients with Chronic Myeloid Leukemia in the Chronic Phase: Single-Center Study

Bassam Francis Matti, Alaadin Sahham Naji, A Alwan · Turkish Journal of Hematology · 2013 · 15 citations · Full text

Cytogenetic Response in Chronic Myeloid Leukaemia Patients Treated with Imatinib Mesylate Homolog-Drugs: 6 Year’s Transitional Study

Najmaddin Khoshnaw, Bassam Francis Matti, Banaz M. Safar et al. · Journal of Cancer Therapy · 2014 · 11 citations · Full text

Group A, Mixed-phenotype Acute Leukemia, Transitional Study +17